CYTOKINE REGULATION OF TROPHOBLAST FUNCTION
滋养层功能的细胞因子调节
基本信息
- 批准号:6225835
- 负责人:
- 金额:$ 7.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-06-01 至 2003-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In humans and primates, trophoblast secretion of chononic gonadotropin (CG) serves as the embryonic signal for maternal recognition of pregnancy. CG is a heterodimeric glycoprotein hormone composed of an alpha-subunit and a distinct CGbeta-subunit. Expression of CG occurs a few days subsequent to fertilization following differentiation of placental cytotrophoblasts into syncytiotrophoblasts. Absence of CG results in the initiation of a new menstrual cycle. Cytokines have been reported to play a role in regulating secretion of CG and have been postulated to modulate cytotrophoblast differentiation. Of these cytokines, interleukin- 6 (IL-6) and leukemia inhibitory factor (LIF; members of the same cytokine family) have been shown to have important roles during pregnancy. LIF is produced by the uterus at the time of blastocyst implantation and can stimulate trophectoderm proliferation in vitro. IL-6 is secreted from a number of cell types within and outside the uteroplacental unit including trophoblasts themselves and as such can act in an autocrine manner to induce secretion of CG. Trophoblast production of IL-6 is stimulated by exposure to the pro-inflammatory cytokine, IL-1. Thus, it is feasible that uterine inflammation would lead to altered secretion of CG. Furthermore, women diagnosed with the pregnancy disorder, preeclampsia, have elevated plasma levels of IL-6 and this is associated with elevated levels of CG in circulation. These and other data implicate IL-6 as being involved in trophoblast physiology as well as pathophysiology. The following specific aims are designed to begin to address the hypothesis that IL-6 regulates trophoblast differentiation and secretion of CG. Specific Aim I: Determine the role of IL-6 in regulating trophoblast proliferation and differentiation. Specific Aim II: Investigate IL-6 regulation of gene expression in trophoblasts using gene array technology. Jar choriocarcinoma cells and primary cultures of cytotrophoblasts will be used to address these aims. It is anticipated that data obtained from these experiments will establish IL-6 as being a critical regulator of trophoblast function and will begin to shed light on how IL-6 regulates trophoblast differentiation. The long term goal of these studies is to better understand maternal/fetal cytokine regulation of trophoblast function and ultimately how trophoblast secretory products modulate the maternal immune system to maintain pregnancy.
在人类和灵长类动物中,滋养层分泌的绒毛膜促性腺激素(CG)作为母体识别妊娠的胚胎信号。CG是由α亚基和不同的CG β亚基组成的异二聚体糖蛋白激素。CG的表达发生在受精后几天,胎盘细胞滋养层细胞分化为合体滋养层细胞。CG的缺乏导致新的月经周期的开始。据报道,细胞因子在调节CG分泌中起作用,并被假定调节细胞滋养层分化。在这些细胞因子中,白细胞介素-6(IL-6)和白血病抑制因子(LIF;同一细胞因子家族的成员)已被证明在怀孕期间发挥重要作用。LIF在胚泡植入时由子宫产生,并且可以在体外刺激滋养外胚层增殖。IL-6由子宫胎盘单位内外的多种细胞类型分泌,包括滋养层细胞本身,因此可以自分泌方式诱导CG分泌。通过暴露于促炎细胞因子IL-1刺激滋养层产生IL-6。因此,子宫炎症可能导致CG分泌改变。此外,被诊断患有妊娠障碍、先兆子痫的妇女具有升高的IL-6血浆水平,并且这与循环中升高的CG水平相关。这些和其他数据暗示IL-6参与滋养层生理学以及病理生理学。以下具体目的旨在开始解决IL-6调节滋养层分化和CG分泌的假设。特定目的I:确定IL-6在调节滋养层细胞增殖和分化中的作用。具体目的二:利用基因芯片技术研究IL-6对滋养层细胞基因表达的调控。罐状绒毛膜癌细胞和原代培养的细胞滋养层细胞将用于解决这些目标。预期从这些实验获得的数据将确立IL-6作为滋养层功能的关键调节剂,并且将开始阐明IL-6如何调节滋养层分化。这些研究的长期目标是更好地了解母体/胎儿滋养层功能的细胞因子调节,并最终了解滋养层分泌产物如何调节母体免疫系统以维持妊娠。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL W WOLFE其他文献
MICHAEL W WOLFE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL W WOLFE', 18)}}的其他基金
CORE B - Stem Cell and Trophoblast Analysis Core
CORE B - 干细胞和滋养层分析核心
- 批准号:
8897427 - 财政年份:2015
- 资助金额:
$ 7.5万 - 项目类别:
Regulation and function of Egr in gonadotropes.
促性腺激素中 EGR 的调节和功能。
- 批准号:
7173312 - 财政年份:2004
- 资助金额:
$ 7.5万 - 项目类别:
Regulation and function of Egr in gonadotropes.
促性腺激素中 EGR 的调节和功能。
- 批准号:
6761618 - 财政年份:2004
- 资助金额:
$ 7.5万 - 项目类别:
Regulation and function of Egr in gonadotropes.
促性腺激素中 EGR 的调节和功能。
- 批准号:
7017690 - 财政年份:2004
- 资助金额:
$ 7.5万 - 项目类别:
Regulation and function of Egr in gonadotropes.
促性腺激素中 EGR 的调节和功能。
- 批准号:
6852600 - 财政年份:2004
- 资助金额:
$ 7.5万 - 项目类别:
TRANSCRIPTIONAL REGULATION OF GONADOTROPIN BETA SUBUNITS DURING DEVELOPMENT
发育过程中促性腺激素β亚基的转录调控
- 批准号:
6316696 - 财政年份:2000
- 资助金额:
$ 7.5万 - 项目类别:
TRANSCRIPTIONAL REGULATION OF GONADOTROPIN BETA SUBUNITS DURING DEVELOPMENT
发育过程中促性腺激素β亚基的转录调控
- 批准号:
6108826 - 财政年份:1999
- 资助金额:
$ 7.5万 - 项目类别:
TRANSCRIPTIONAL REGULATION OF GONADOTROPIN BETA SUBUNITS DURING DEVELOPMENT
发育过程中促性腺激素β亚基的转录调控
- 批准号:
6272386 - 财政年份:1998
- 资助金额:
$ 7.5万 - 项目类别:
TRANSCRIPTIONAL REGULATION OF GONADOTROPIN BETA SUBUNITS DURING DEVELOPMENT
发育过程中促性腺激素β亚基的转录调控
- 批准号:
6241349 - 财政年份:1997
- 资助金额:
$ 7.5万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 7.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 7.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 7.5万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 7.5万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 7.5万 - 项目类别:
Studentship